Martin Heidecker
InvestorChief Investment Officer at AMR Action Fund · Board director at Rgenta Therapeutics · Board director at Elion Therapeutics · Board director at Abexxa Biologics
Cambridge, Massachusetts, United States
Find your path to Martin
118 people in our graph share verified history with Martin — schools, employers, funds. One of them is your warm intro.
Aleks EngelunlockedMartin: together at AMR Action Fund (2020–2024)
×3Martin: together at Solvay Pharmaceuticals
Martin: together at MassBio
×4Martin: together at The Julius Maximilians University of Würzburg
About
Joined the fund in 2021 with extensive venture capital and drug development experience. Previously Managing Director USA of Boehringer Ingelheim Venture Fund and began his investing career at Bayern Kapital in Germany.
Contact· published on Martin's own website
Board director at Rgenta Therapeutics
Intro paths
→
In turn, Martin can intro founders to Rgenta Therapeutics's investors below.
Rgenta Therapeutics's investors · 8
AMR Action FundBoston · since 2020Boehringer Ingelheim Venture FundIngelheim am Rhein · $16.2M checks · since 2022Delos CapitalCambridge · since 2021Korea Investment PartnersSeoul · $973K – $50M checks · since 2021Lilly Asia VenturesHong Kong · since 2020Matrix Capital ManagementPortsmouth · since 2021Matrix Partners ChinaBeijing · $1.6M – $113M checks · since 2022Vivo CapitalPalo Alto · $10M – $50M checks · since 2021
Co-founders at Rgenta Therapeutics
TW
Travis WagerCo-founder, President and CSO
HS
Hualin Simon XiExecutive Officer, Director
ZW
Zhiping WengCo-founder
SX
Simon XiCo-founder and CEO
Board director at Elion Therapeutics
Intro paths
→
In turn, Martin can intro founders to Elion Therapeutics's investors below.
Elion Therapeutics's investors · 3
Board director at Abexxa Biologics
Intro paths
→
In turn, Martin can intro founders to Abexxa Biologics's investors below.
Abexxa Biologics's investors · 1
Co-founders at Abexxa Biologics
JW
Jon WeidanzDirector and President
DW
Debra WeidanzCEO and Director
Experience
- AMR Action FundChief Investment Officercurrent2021 — presentBoston, Massachusetts, United States
- AMR Action FundMember Board of Directors AMR action2020 — 2021
- MassBioBoard Member MassBio Biotechnologycurrent2020 — presentCambridge, Massachusetts, United States
- Libra TherapeuticsMember Board of Directors Libra Therapeutics Inc.2020 — 2021San Diego, California, United States
- Tiga Therapeutics Inc.Member Board of Directors Tiga Tx Inc.2020 — 2021Cambridge, Massachusetts, United States
- Rgenta Therapeutics Inc.Member Board of Directors Rgenta Therapeutics Inc.2020 — 2021Cambridge, Massachusetts, United States
- Abexxa Biologics, Inc.Member Board of Directors Abexxa Biologics Inc.2016 — 2021Arlington, Texas, United States
- Sentien Biotechnologies, Inc.Member Board of Directors2015 — 2021Medford, MA
- Boehringer Ingelheim Venture Fund USA Inc.Managing Director BIVF USA Inc.2013 — 2021Cambridge, Massachusetts
- ArmaGen TechnologiesMember Board of Directors2012 — 2020Calabasis, California
- 121 Bio LLCMember Board of Directors2014 — 2016Cambridge, MA
- AMP TherapeuticsMember Board of Directors2012 — 2015Leipzig Area, Germany
- Boehringer IngelheimDirector, Investment Manager2010 — 2013Ingelheim, Germany
- Boehringer IngelheimTeam Leader Business Analysis CNS&Oncology2009 — 2010Ingelheim, Germany
- Boehringer IngelheimSenior International Manager Business Analysis2007 — 2009
- Solvay Pharmaceuticals GmbH - Solvay HQSenior Global Business Analyst2004 — 2007
- Solvay PharmaceuticalsGlobal Business Analyst2004 — 2007
- DEWB, BayernkapitalInvestment Manager2001 — 2004
Skills & more
Oncology46Biotechnology51Market Research32Lifesciences12Clinical Development21Market Access12Biopharmaceuticals19Business Analysis9Drug Discovery10Neurology7Market Analysis14Pharmaceutical Sales8
+12 more
Drug DevelopmentTechnology TransferGlobal MarketingSales EffectivenessCompetitive IntelligenceCardiologyClinical TrialsCommercializationPharmaceutical IndustryMedical DevicesVaccinesDiabetesFrom Martin's professional profile.
Deals · 4
Vedanta BiosciencesBoard seat
via AMR Action Fund · filed Aug 2024 · $118.5M raise
Adaptive Phage TherapeuticsBoard seat
via AMR Action Fund · filed Jun 2023 · $30M raise
Rgenta TherapeuticsBoard seat
via AMR Action Fund · filed Mar 2021 · $38M raise
Abexxa BiologicsBoard seat
via AMR Action Fund · filed Sep 2016 · $1.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Elion TherapeuticsVenatorx Pharmaceuticals
Per SEC Form D filings.
Colleagues at AMR Action Fund
Bill Burns
Board Chair at AMR Action Fund
Carly Levine
Senior Associate at AMR Action Fund
Chris Sweeney
Executive Director, Communications and Media Relations at AMR Action Fund
Corinna Ruppli
Office Manager at AMR Action Fund
David Hellmuth
General Counsel and COO at AMR Action Fund
Deepali Patel
Director of International Policy at AMR Action Fund
Dorothy Maloney
Compliance Officer at AMR Action Fund
Henni-Karoliina Ropponen
Venture Analyst at AMR Action Fund
Frequently asked questions
- Who is Martin Heidecker?
- Joined the fund in 2021 with extensive venture capital and drug development experience. Previously Managing Director USA of Boehringer Ingelheim Venture Fund and began his investing career at Bayern Kapital in Germany.
- Where does Martin Heidecker work?
- Martin Heidecker is Chief Investment Officer at AMR Action Fund and Board director at Rgenta Therapeutics and Board director at Elion Therapeutics and Board director at Abexxa Biologics.
- What boards does Martin Heidecker sit on?
- Martin Heidecker holds tracked board seats at Abexxa Biologics, Adaptive Phage Therapeutics, Elion Therapeutics, Rgenta Therapeutics, Vedanta Biosciences, Venatorx Pharmaceuticals.
- Where did Martin Heidecker go to school?
- Martin Heidecker studied at The Julius Maximilians University of Würzburg (Doctor of Philosophy (PhD), Biology).
Same school
Also attended The Julius Maximilians University of Würzburg33
Kilian ThalhammerAdvisor, Business Angel, Payments Expert, Board, NED — Fintech at heartAlexander Meyer-ScharenbergPartner at Alstin CapitalHolger WagnerInvestment Director at EnBW New Ventures GmbHJim CurryCo-Founder and CEO at BuildGroupMaximilian OchsInvestor at First MomentumFlorian LöbermannPartner at GET Fund
+ 27 more
Shared employers
Also worked at AMR Action Fund10
Aleks EngelPartner at Novo HoldingsCarly LevineSenior Associate at AMR Action FundJohn VancuraCFO at AMR Action FundJunjun GaoPrincipal at AMR Action FundHenni-Karoliina RopponenVenture Analyst at AMR Action FundIsabella SantiVenture Analyst at AMR Action Fund
+ 4 more
Also worked at MassBio15
Christopher de SouzaDirector at Broadview VenturesGlenn BatchelderVenture Partner at Pivotal Life SciencesChandra RamanathanAdvisor, Biotech at Iaso VenturesJanice BourqueManaging Director of Life Sciences, Hercules Capital at Foreground CapitalRakhshita DharInvestor at Leaps by BayerNathan DavisAnalyst at RA Capital
+ 9 more
